RecruitingNot applicableNCT05186064

Glioblastoma Targeted Treatment Option Maximization by WGS

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UMC Utrecht
Intervention
whole genome sequencing(diagnostic_test)
Enrollment
160 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Amsterdam University Medical Center · The Netherlands Cancer Institute · The Elisabeth-TweeSteden Hospital · Erasmus Medical Center · Medical Center Haaglanden · Isala · Leiden University Medical Center · Maastricht University Medical Center · Medisch Spectrum Twente · Radboud University Medical Center · University Medical Center Groningen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05186064 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials